🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a single-center, multiple-dose, randomized, double-blind, placebo-...
Status
Completed
Location
PRA International Clinical Pharmacology Center (EDS US Clinic)
Start Date
2019-02-07
Trial ID
NCT03808298
Treatments Being Tested
This study will evaluate the efficacy, safety, and pharmacokinetics of 10 m...
Status
Terminated
Location
Harmonex Neuroscience Research
Start Date
2018-08-08
Trial ID
NCT03504917
Treatments Being Tested
This is a multi-center, non-randomized, open-label, parallel group, multipl...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-06-26
Trial ID
NCT03912350
Treatments Being Tested
This study will investigate the effect of food and the effect of esomeprazo...
Status
Completed
Location
PRA International Clinical Pharmacology Center (EDS US Clinic)
Start Date
2019-11-19
Trial ID
NCT04156646
Treatments Being Tested
This was a Phase Ib, multicenter, open-label study in children 2-4 years ol...
Status
Terminated
Location
Southwest Autism Research & Resource Center
Start Date
2019-12-19
Trial ID
NCT04049578
Treatments Being Tested
For participants enrolled prior to Version 6 of the protocol: This was a Ph...
Status
Terminated
Location
Harmonex Neuroscience Research
Start Date
2016-11-21
Trial ID
NCT02901431
This study was a non-randomized, open-label, parallel group, two-treatment ...
Status
Completed
Location
Pra International Group B.V
Start Date
2019-01-10
Trial ID
NCT03764449
Treatments Being Tested
This study was a non-randomized, open-label, one-sequence, two-period withi...
Status
Completed
Location
Pra International Group B.V
Start Date
2018-07-10
Trial ID
NCT03579719
Treatments Being Tested
This study will evaluate the efficacy and safety of 10 mg of oral administr...
Status
Completed
Location
Alea Research
Start Date
2022-08-02
Trial ID
NCT05401565
Treatments Being Tested